PROTEOSTASIS THERAPEUTICS IN's ticker is PTI and the CUSIP is 74373B109. A total of 90 filers reported holding PROTEOSTASIS THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,016,000 | -62.7% | 313,466 | -72.2% | 0.10% | -41.7% |
| Q3 2018 | $2,721,000 | -9.5% | 1,129,121 | +4.8% | 0.16% | -24.9% |
| Q2 2018 | $3,006,000 | -42.7% | 1,077,408 | -2.5% | 0.22% | -56.5% |
| Q1 2018 | $5,248,000 | -40.0% | 1,104,940 | -26.3% | 0.50% | -65.8% |
| Q4 2017 | $8,745,000 | – | 1,500,000 | – | 1.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,804,027 | $17,803,000 | 2.95% |
| HARBOURVEST PARTNERS LLC | 440,627 | $2,062,000 | 0.89% |
| NEA Management Company, LLC | 3,556,778 | $16,646,000 | 0.61% |
| Rock Springs Capital Management LP | 450,000 | $2,106,000 | 0.11% |
| Bain Capital Public Equity Management, LLC | 263,498 | $1,233,000 | 0.07% |
| ELEMENT CAPITAL MANAGEMENT LLC | 65,973 | $309,000 | 0.06% |
| Hillhouse Capital Management | 865,923 | $4,053,000 | 0.06% |
| SABBY MANAGEMENT, LLC | 125,151 | $586,000 | 0.04% |
| Marshall Wace North America L.P. | 684,124 | $3,421,000 | 0.02% |
| FNY Partners Fund LP | 20,127 | $94,000 | 0.02% |